Non-dopamine lesions in Parkinson's disease /

Parkinson's disease becomes apparent only after substantial loss (& 60%) of the dopamine neurons in the substantia nigra. By this time there has already been widespread neural inclusion formation in the peripheral and central nervous system of patients with the disease, although this has on...

Full description

Saved in:
Bibliographic Details
Online Access: Full text (MCPHS users only)
Other Authors: Halliday, Glenda M., Barker, Roger A., 1961-, Rowe, Dominic B.
Format: Electronic eBook
Language:English
Published: New York : Oxford University Press, 2011
Subjects:
Local Note:ProQuest Ebook Central

MARC

LEADER 00000cam a2200000 a 4500
001 in00000142991
006 m o d
007 cr cnu---unuuu
008 100930s2011 nyu ob 001 0 eng d
005 20240701203829.5
016 7 |a 101524364  |2 DNLM 
019 |a 691852642  |a 698431293  |a 746326592  |a 990681844  |a 1015853082  |a 1055324596  |a 1066666697  |a 1081290613 
020 |a 9780199707881  |q (electronic bk.) 
020 |a 019970788X  |q (electronic bk.) 
020 |a 0195371089  |q (alk. paper) 
020 |a 9780195371086  |q (alk. paper) 
029 1 |a DEBBG  |b BV043074583 
029 1 |a DEBSZ  |b 424613808 
035 |a (OCoLC)667231115  |z (OCoLC)691852642  |z (OCoLC)698431293  |z (OCoLC)746326592  |z (OCoLC)990681844  |z (OCoLC)1015853082  |z (OCoLC)1055324596  |z (OCoLC)1066666697  |z (OCoLC)1081290613 
035 |a (OCoLC)ocn667231115 
040 |a N$T  |b eng  |e pn  |c N$T  |d YDXCP  |d EBLCP  |d OCLCQ  |d MHW  |d OCLCQ  |d OCLCF  |d OCLCQ  |d UAB  |d E7B  |d CDX  |d DG1  |d CUS  |d OCLCQ  |d D6H  |d STBDS  |d AGLDB  |d DG1  |d LGG  |d PIFAG  |d OCLCQ  |d OCLCO  |d WY@  |d OCLCO  |d OCLCA  |d LUE  |d OCLCO  |d OCLCQ  |d VNS  |d VTS  |d CUY  |d MERUC  |d ZCU  |d ICG  |d VT2  |d OCLCQ  |d WYU  |d REC  |d OCLCQ  |d STF  |d OCLCO  |d OCLCQ  |d DKC  |d AU@  |d OCLCO  |d OCLCQ  |d M8D  |d OCLCO  |d OCLCQ  |d OCLCA  |d LIP  |d AJS  |d UKAHL  |d OCLCQ  |d OCLCO  |d ANO  |d OCL  |d OCLCQ  |d OCLCO  |d OCLCL 
050 4 |a RC382  |b .N637 2011eb 
060 4 |a WL 359  |b N8128 2011 
072 7 |a HEA  |x 039140  |2 bisacsh 
072 7 |a MED  |x 056000  |2 bisacsh 
082 0 4 |a 616.8/33  |2 22 
245 0 0 |a Non-dopamine lesions in Parkinson's disease /  |c edited by Glenda M. Halliday, Roger A. Barker, Dominic B. Rowe. 
260 |a New York :  |b Oxford University Press,  |c 2011. 
300 |a 1 online resource (xxi, 314 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
505 0 |a Lesions associated with the classic triad of Parkinsonian motor features / Stanley Fahn and Glenda M. Halliday -- Lesions associated with motor speech / Anna Rita Bentivoglio, Davide Quaranta, and Aileen K. Ho -- Lesions associated with eye movements / Andrew W. Michell, Roger A. Barker, and Glenda M. Halliday -- Olfactory dysfunction in Parkinson's disease and related disorders / Richard L. Doty, Christopher Hawkes, and Henk W. Berendse -- Lesions associated with autonomic dysfunction. Swallowing disorders and drooling / Maria G. Cersosimo and Eduardo E. Bennarroch. Gastrointestinal disorders / Adolfo Mínguez-Castellanos and Dominic B. Rowe. Orthostatic hypotension / Spiridon Papapetropoulos and Kathryn K. Post -- Lesions associated with pain and sensory abnormalities / Andreas Hartmann and Glenda M. Halliday -- Lesions associated with sleep disturbances / Marcus M. Unger [and others] -- Lesions associated with depression and apathy / Uwe Ehrt, Kenn F. Pedersen, and Dag Aarsland -- Lesions associated with dyskinesias and the dopamine dysregulation syndrome / Andrew H. Evans -- Lesions associated with visual hallucinations and psychoses / David R. Williams and Werner Poewe -- Lesions associated with cognitive impairment and dementia / Jonathan Evans, Tamas Revesz, and Roger A. Barker -- Systemic manifestations of Parkinson's disease / Dominic B. Rowe. 
520 |a Parkinson's disease becomes apparent only after substantial loss (& 60%) of the dopamine neurons in the substantia nigra. By this time there has already been widespread neural inclusion formation in the peripheral and central nervous system of patients with the disease, although this has only been recognized more recently. Degeneration in these widespread regions of the peripheral and central nervous system is now known to impact on disease symptoms, progression and treatment over time. This book aims to provide a comprehensive review of these non-dopamine lesions in Parkinson's disease by assessing our current knowledge of their presence and pathophysiology, how they relate to different symptoms and, where relevant, discuss how they may be potentially treated. 
546 |a English. 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central College Complete 
650 0 |a Parkinson's disease  |x Pathophysiology. 
650 0 |a Dopamine. 
650 1 2 |a Parkinson Disease  |x physiopathology 
650 2 2 |a Brain  |x pathology 
650 2 2 |a Dopamine 
650 2 2 |a Parkinson Disease  |x complications 
700 1 |a Halliday, Glenda M. 
700 1 |a Barker, Roger A.,  |d 1961-  |1 https://id.oclc.org/worldcat/entity/E39PBJxhggJPVDygYqy6mYHXBP 
700 1 |a Rowe, Dominic B. 
758 |i has work:  |a Non-dopamine lesions in Parkinson's disease (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFGYBJjYMRGVGJVyCMkgPP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Non-dopamine lesions in Parkinson's disease.  |d New York : Oxford University Press, 2011  |z 9780195371086  |w (DLC) 2010006010  |w (OCoLC)529295607 
852 |b E-Collections  |h ProQuest 
856 4 0 |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=584585  |z Full text (MCPHS users only)  |t 0 
938 |a Askews and Holts Library Services  |b ASKH  |n AH26310868 
938 |a Askews and Holts Library Services  |b ASKH  |n AH24086747 
938 |a Coutts Information Services  |b COUT  |n 15220989 
938 |a EBL - Ebook Library  |b EBLB  |n EBL584585 
938 |a ebrary  |b EBRY  |n ebr10416906 
938 |a EBSCOhost  |b EBSC  |n 336204 
938 |a Oxford University Press USA  |b OUPR  |n EDZ0000173009 
938 |a YBP Library Services  |b YANK  |n 3491785 
938 |a YBP Library Services  |b YANK  |n 12890515 
947 |a FLO  |x pq-ebc-base 
999 f f |s 4b514535-bdf6-452b-9024-f779774d41b1  |i 21fe740c-800b-4bbc-9862-5fd55dc77438  |t 0 
952 f f |a Massachusetts College of Pharmacy and Health Sciences  |b Online  |c Online  |d E-Collections  |t 0  |e ProQuest  |h Other scheme 
856 4 0 |t 0  |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=584585  |y Full text (MCPHS users only)